Abiomed Net Income

Abiomed (ABMD) currently reports a net income of $270M as of September 2022. That compares with $150M in the prior-year period — up 78.9% year over year. That is below the Healthcare sector average of $16B. Use the charts on this page to explore Abiomed's net income history and peer comparisons.

Abiomed's net income increased from $150M to $270M — a 78.9% year-over-year increase (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Abiomed's net income of $270M is lower than the Healthcare sector average of $16B. That is roughly 98.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Abiomed reported $270M in net income as of September 2022. That compares with $150M in the prior-year period — up 78.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $270M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $16B. From there, open related valuation or income-statement pages for Abiomed, and consider following ABMD for alerts when major investors trade the stock.